Skip to content
TrialScanner

NCT04167137

Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants

Phase 1TerminatedSYBXLeadIQVCollaborator

Registry record

Lead sponsor
Synlogic
Conditions
Metastatic Solid Neoplasm; Lymphoma
Primary completion
Dec 9, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04167137 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04167137: Safety and Tolerability of... | TrialScanner